Source: |
Type: |
Beta-Amyloid (Aβ): In Alzheimer’s disease, Aβ peptides tend to misfold and aggregate into oligomers and fibrils. |
3864- | ACNs, | Anthocyanins Potentially Contribute to Defense against Alzheimer’s Disease |
- | Review, | AD, | NA |
3447- | ALA, | Redox Active α-Lipoic Acid Differentially Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer and Its Control Cells |
- | in-vitro, | AD, | SH-SY5Y |
3440- | ALA, | Protective effects of alpha lipoic acid (ALA) are mediated by hormetic mechanisms |
- | Review, | AD, | NA |
3271- | ALA, | Decrypting the potential role of α-lipoic acid in Alzheimer's disease |
- | Review, | AD, | NA |
3269- | ALA, | Sulfur-containing therapeutics in the treatment of Alzheimer’s disease |
- | NA, | AD, | NA |
3545- | ALA, | Potential therapeutic effects of alpha lipoic acid in memory disorders |
- | Review, | AD, | NA |
3546- | ALA, | Cognitive and Mood Effect of Alpha-Lipoic Acid Supplementation in a Nonclinical Elder Sample: An Open-Label Pilot Study |
- | Study, | AD, | NA |
3549- | ALA, | Important roles of linoleic acid and α-linolenic acid in regulating cognitive impairment and neuropsychiatric issues in metabolic-related dementia |
- | Review, | AD, | NA |
3882- | Api, | Enhancing Amyloid-β Clearance May Improve Brain Function in Alzheimer Disease |
- | Review, | AD, | NA |
3884- | Api, | Neuroprotective, Anti-Amyloidogenic and Neurotrophic Effects of Apigenin in an Alzheimer’s Disease Mouse Model |
- | in-vivo, | AD, | NA |
3887- | Api, | The flavonoid apigenin protects brain neurovascular coupling against amyloid-β₂₅₋₃₅-induced toxicity in mice |
- | in-vivo, | AD, | NA |
4280- | Api, | Protective effects of apigenin in neurodegeneration: An update on the potential mechanisms |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3819- | Aroma, | Aromatherapy improves cognitive dysfunction in senescence-accelerated mouse prone 8 by reducing the level of amyloid beta and tau phosphorylation |
- | Human, | AD, | NA | - | in-vitro, | AD, | NA |
3688- | Ash, | Withaferin A Suppresses Beta Amyloid in APP Expressing Cells: Studies for Tat and Cocaine Associated Neurological Dysfunctions |
- | NA, | AD, | SH-SY5Y |
3687- | Ash, | Role of Withaferin A and Its Derivatives in the Management of Alzheimer’s Disease: Recent Trends and Future Perspectives |
- | Review, | AD, | NA |
4303- | Ash, | Ashwagandha (Withania somnifera)—Current Research on the Health-Promoting Activities: A Narrative Review |
- | Review, | AD, | NA |
3675- | Ash, | Ashwagandha (Withania somnifera) Reverses β-Amyloid1-42 Induced Toxicity in Human Neuronal Cells: Implications in HIV-Associated Neurocognitive Disorders (HAND) |
3668- | Ash, | Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver |
- | NA, | AD, | NA |
3754- | BBR, | CUR, | EGCG, | Hup, | Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer’s disease: A review |
3833- | BBR, | Traditional Chinese Medicine: Role in Reducing β-Amyloid, Apoptosis, Autophagy, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction of Alzheimer’s Disease |
- | Review, | AD, | NA |
4300- | BBR, | Effect of berberine on cognitive function and β-amyloid precursor protein in Alzheimer’s disease models: a systematic review and meta-analysis |
- | Review, | AD, | NA |
3678- | BBR, | Network pharmacology study on the mechanism of berberine in Alzheimer’s disease model |
- | Review, | AD, | NA |
3677- | BBR, | Berberine: A Potential Multipotent Natural Product to Combat Alzheimer’s Disease |
- | Review, | AD, | NA |
3679- | BBR, | Berberine alleviates Alzheimer's disease by activating autophagy and inhibiting ferroptosis through the JNK-p38MAPK signaling pathway |
- | in-vivo, | AD, | NA |
3680- | BBR, | Network pharmacology reveals that Berberine may function against Alzheimer’s disease via the AKT signaling pathway |
- | in-vivo, | AD, | NA |
3682- | BBR, | Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer’s Disease |
- | in-vitro, | AD, | NA |
4080- | betaCar, | Vitamin A and Alzheimer's disease |
- | Review, | AD, | NA |
3692- | BM, | Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease |
- | Review, | AD, | NA |
3693- | BM, | Bacopa monnieri prevents colchicine-induced dementia by anti-inflammatory action |
- | in-vivo, | AD, | NA |
3785- | Bor, | Discovery of boron-containing compounds as Aβ aggregation inhibitors and antioxidants for the treatment of Alzheimer's disease |
- | Analysis, | AD, | NA |
760- | Bor, | Therapeutic Efficacy of Boric Acid Treatment on Brain Tissue and Cognitive Functions in Rats with Experimental Alzheimer’s Disease |
- | in-vivo, | AD, | NA |
4270- | Bos, | Boswellic acids ameliorate neurodegeneration induced by AlCl3: the implication of Wnt/β-catenin pathway |
- | in-vivo, | AD, | NA |
3866- | Bos, | Mechanistic role of boswellic acids in Alzheimer's disease: Emphasis on anti-inflammatory properties |
- | Review, | AD, | NA |
4263- | CA, | Neuroprotective Effects of Carnosic Acid: Insight into Its Mechanisms of Action |
- | Review, | AD, | NA |
3855- | CAP, | Capsaicin consumption reduces brain amyloid-beta generation and attenuates Alzheimer’s disease-type pathology and cognitive deficits in APP/PS1 mice |
- | in-vivo, | AD, | NA |
3854- | CAP, | Capsaicin consumption reduces brain amyloid-beta generation and attenuates Alzheimer’s disease-type pathology and cognitive deficits in APP/PS1 mice |
- | in-vivo, | AD, | NA |
3873- | Carno, | Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice |
- | in-vivo, | AD, | NA |
3872- | Carno, | Carnosine Protects Macrophages against the Toxicity of Aβ1-42 Oligomers by Decreasing Oxidative Stress |
- | in-vitro, | AD, | NA |
3874- | Carno, | Effects of zinc and carnosine on aggregation kinetics of Amyloid-β40 peptide |
- | Review, | AD, | NA |
3870- | Carno, | Could carnosine or related structures suppress Alzheimer's disease? |
- | Review, | AD, | NA |
3869- | Carno, | Carnosine, Small but Mighty—Prospect of Use as Functional Ingredient for Functional Food Formulation |
- | Review, | AD, | NA | - | Review, | Stroke, | NA |
3701- | Chol, | Lifelong choline supplementation ameliorates Alzheimer's disease pathology and associated cognitive deficits by attenuating microglia activation |
- | in-vivo, | AD, | NA |
- | Review, | AD, | NA | - | Review, | Var, | NA |
3889- | Cin, | Orally administrated cinnamon extract reduces β-amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal models |
- | in-vivo, | AD, | NA |
3888- | Cin, | Cinnamon, a promising prospect towards Alzheimer's disease |
- | NA, | AD, | NA |
3993- | CoQ10, | Coenzyme Q10 Decreases Amyloid Pathology and Improves Behavior in a Transgenic Mouse Model of Alzheimer’s Disease |
- | Review, | Park, | NA | - | Review, | AD, | NA |
3625- | Croc, | Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial |
- | Trial, | AD, | NA |
3627- | Croc, | The effects of Crocus sativus (saffron) and its constituents on nervous system: A review |
- | Review, | AD, | NA | - | Review, | Stroke, | NA |
3628- | Croc, | VitE, | CUR, | Vitamin E, Turmeric and Saffron in Treatment of Alzheimer’s Disease |
- | Review, | AD, | NA |
3631- | Croc, | Investigation of the neuroprotective effects of crocin via antioxidant activities in HT22 cells and in mice with Alzheimer's disease |
- | in-vitro, | AD, | HT22 | - | in-vivo, | AD, | NA |
3624- | Croc, | Crocus Sativus L. (Saffron) in Alzheimer's Disease Treatment: Bioactive Effects on Cognitive Impairment |
- | Review, | AD, | NA |
2816- | CUR, | NEUROPROTECTIVE EFFECTS OF CURCUMIN |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3793- | CUR, | Curcumin Downregulates GSK3 and Cdk5 in Scopolamine-Induced Alzheimer’s Disease Rats Abrogating Aβ40/42 and Tau Hyperphosphorylation |
- | in-vivo, | AD, | NA |
3795- | CUR, | Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence |
- | Review, | AD, | NA |
3748- | CUR, | RES, | Hup, | Riv, | Gala | Natural acetylcholinesterase inhibitors: A multi-targeted therapeutic potential in Alzheimer's disease |
- | Review, | AD, | NA |
3860- | CUR, | Curcumin Ameliorates Memory Decline via Inhibiting BACE1 Expression and β-Amyloid Pathology in 5×FAD Transgenic Mice |
- | in-vivo, | AD, | NA |
3574- | CUR, | The effect of curcumin (turmeric) on Alzheimer's disease: An overview |
- | Review, | AD, | NA |
3575- | CUR, | The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse |
- | in-vivo, | AD, | NA |
3576- | CUR, | Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease |
- | Review, | AD, | NA |
3584- | CUR, | Curcumin in Health and Diseases: Alzheimer’s Disease and Curcumin Analogues, Derivatives, and Hybrids |
3707- | dietSTF, | Intermittent fasting protects against the deterioration of cognitive function, energy metabolism and dyslipidemia in Alzheimer’s disease-induced estrogen deficient rats |
- | in-vivo, | AD, | NA |
3709- | dietSTF, | Intermittent Fasting Protects against Alzheimer’s Disease Possible through Restoring Aquaporin-4 Polarity |
- | in-vitro, | AD, | NA |
3593- | EGCG, | Epigallocatechin Gallate (EGCG) |
- | Review, | AD, | NA |
3591- | EGCG, | Epigallocatechin-3-Gallate Provides Protection Against Alzheimer's Disease-Induced Learning and Memory Impairments in Rats |
- | in-vivo, | AD, | NA |
3232- | EGCG, | (−)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer׳s disease model mice by upregulating neprilysin expression |
- | in-vivo, | AD, | NA |
3237- | EGCG, | (-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression |
- | in-vivo, | AD, | NA |
3830- | EMD, | Traditional Chinese Medicine: Role in Reducing β-Amyloid, Apoptosis, Autophagy, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction of Alzheimer’s Disease |
- | Review, | AD, | NA |
3783- | FA, | Design, Synthesis, and Biological Evaluation of Ferulic Acid-Piperazine Derivatives Targeting Pathological Hallmarks of Alzheimer’s Disease |
- | NA, | AD, | NA |
3782- | FA, | Ferulic acid ameliorates bisphenol A (BPA)-induced Alzheimer’s disease-like pathology through Akt-ERK crosstalk pathway in male rats |
- | in-vivo, | AD, | NA |
3710- | FA, | Therapeutic Potential of Ferulic Acid in Alzheimer's Disease |
- | Review, | AD, | NA |
3711- | FA, | A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease |
- | Review, | AD, | NA |
3712- | FA, | Ferulic Acid: A Hope for Alzheimer’s Disease Therapy from Plants |
- | Review, | AD, | NA |
3713- | FA, | Protective Effect of Ferulic Acid on Acetylcholinesterase and Amyloid Beta Peptide Plaque Formation in Alzheimer’s Disease: An In Vitro Study |
- | Review, | AD, | NA |
3714- | FA, | Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer's Disease: A Narrative Review |
- | Review, | AD, | NA |
3715- | FA, | CUR, | PS, | The Additive Effects of Low Dose Intake of Ferulic Acid, Phosphatidylserine and Curcumin, Not Alone, Improve Cognitive Function in APPswe/PS1dE9 Transgenic Mice |
- | in-vivo, | AD, | NA |
3717- | FA, | Neuroprotective Properties of Ferulic Acid in Preclinical Models of Alzheimer's Disease: A Systematic Literature Review |
- | Review, | AD, | NA |
3779- | FA, | A review on ferulic acid and analogs based scaffolds for the management of Alzheimer’s disease |
- | Review, | AD, | NA |
3778- | FA, | Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer’s Disease: A Narrative Review |
- | Review, | AD, | NA |
4071- | FA, | Folate and Alzheimer: when time matters |
- | Review, | AD, | NA |
4070- | FA, | Folic Acid Supplementation Mitigates Alzheimer's Disease by Reducing Inflammation: A Randomized Controlled Trial |
- | Trial, | AD, | NA |
4068- | FA, | Hyperhomocysteinemia in Alzheimer's disease: the hen and the egg? |
- | in-vivo, | AD, | NA |
2861- | FIS, | The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress |
- | Review, | Nor, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
4107- | FLS, | Ex, | Combined effects of aerobic exercise and 40-Hz light flicker exposure on early cognitive impairments in Alzheimer's disease of 3×Tg mice |
- | in-vivo, | AD, | NA |
4018- | FulvicA, | Fe, | Inhibitory Impacts of Fulvic Acid-Coated Iron Oxide Nanoparticles on the Amyloid Fibril Aggregations |
- | in-vivo, | AD, | NA |
3721- | Gb, | Ginkgo biloba Extract in Alzheimer’s Disease: From Action Mechanisms to Medical Practice |
- | Review, | AD, | NA |
3723- | Gb, | Can We Use Ginkgo biloba Extract to Treat Alzheimer’s Disease? Lessons from Preclinical and Clinical Studies |
- | Review, | AD, | NA |
3829- | Gins, | Traditional Chinese Medicine: Role in Reducing β-Amyloid, Apoptosis, Autophagy, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction of Alzheimer’s Disease |
- | Review, | AD, | NA |
4302- | Gins, | Panax ginseng: A modulator of amyloid, tau pathology, and cognitive function in Alzheimer's disease |
- | Review, | AD, | NA |
4003- | Gins, | Neuroprotective Potentials of Panax Ginseng Against Alzheimer's Disease: A Review of Preclinical and Clinical Evidences |
- | Review, | adrenal, | NA |
4004- | Gins, | Effects of fermented ginseng on memory impairment and β-amyloid reduction in Alzheimer’s disease experimental models |
- | in-vivo, | AD, | NA |
3774- | H2, | The role of hydrogen in Alzheimer’s disease |
- | Review, | AD, | NA |
3772- | H2, | Therapeutic potential of hydrogen-rich water in zebrafish model of Alzheimer’s disease: targeting oxidative stress, inflammation, and the gut-brain axis |
- | in-vivo, | AD, | NA |
3764- | H2, | Therapeutic Effects of Hydrogen Gas Inhalation on Trimethyltin-Induced Neurotoxicity and Cognitive Impairment in the C57BL/6 Mice Model |
- | in-vivo, | AD, | NA |
3767- | H2, | The role of hydrogen therapy in Alzheimer's disease management: Insights into mechanisms, administration routes, and future challenges |
- | Review, | AD, | NA |
4307- | H2, | Hydrogen Gas Attenuates Toxic Metabolites and Oxidative Stress-Mediated Signaling to Inhibit Neurodegeneration and Enhance Memory in Alzheimer’s Disease Models |
- | in-vivo, | AD, | NA |
3769- | H2S, | Research progress of hydrogen sulfide in Alzheimer's disease from laboratory to hospital: a narrative review |
- | Review, | AD, | NA |
4238- | HNK, | Neuropharmacological potential of honokiol and its derivatives from Chinese herb Magnolia species: understandings from therapeutic viewpoint |
- | Review, | AD, | NA | - | NA, | Park, | NA |
2894- | HNK, | Pharmacological features, health benefits and clinical implications of honokiol |
- | Review, | Var, | NA | - | Review, | AD, | NA |
2869- | HNK, | Nature's neuroprotector: Honokiol and its promise for Alzheimer's and Parkinson's |
- | Review, | AD, | NA | - | Review, | Park, | NA |
2916- | LT, | Antioxidative and Anticancer Potential of Luteolin: A Comprehensive Approach Against Wide Range of Human Malignancies |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
4292- | LT, | Luteolin for neurodegenerative diseases: a review |
- | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | MS, | NA | - | Review, | Stroke, | NA |
4295- | LT, | Luteolin Reduces Alzheimer’s Disease Pathologies Induced by Traumatic Brain Injury |
- | in-vivo, | AD, | NA |
3977- | Lut, | Zeax, | Dietary carotenoids related to risk of incident Alzheimer dementia (AD) and brain AD neuropathology: a community-based cohort of older adults |
- | Trial, | AD, | NA |
3532- | Lyco, | Lycopene alleviates oxidative stress via the PI3K/Akt/Nrf2pathway in a cell model of Alzheimer’s disease |
- | in-vitro, | AD, | NA |
- | in-vitro, | AD, | NA |
3898- | MCT, | Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer's disease |
- | Review, | AD, | NA |
3725- | MF, | Short-term effects of extremely low frequency electromagnetic fields exposure on Alzheimer's disease in rats |
- | in-vivo, | AD, | NA |
3739- | MF, | Early intervention using long-term rhythmic pulsed magnetic stimulation alleviates cognitive decline in a 5xFAD mouse model of Alzheimer's disease |
- | in-vivo, | AD, | NA |
3740- | MF, | Gamma rhythm low field magnetic stimulation alleviates neuropathologic changes and rescues memory and cognitive impairments in a mouse model of Alzheimer's disease |
- | in-vivo, | AD, | NA |
3735- | MF, | Examining the effects of extremely low-frequency magnetic fields on cognitive functions and functional brain markers in aged mice |
- | in-vivo, | AD, | NA |
4106- | MF, | Cognitive Decline: Current Intervention Strategies and Integrative Therapeutic Approaches for Alzheimer's Disease |
- | Review, | AD, | NA |
4119- | MF, | Therapeutic potential and mechanisms of repetitive transcranial magnetic stimulation in Alzheimer’s disease: a literature review |
- | Review, | AD, | NA |
4118- | MF, | Effects of transcranial magnetic stimulation on neurobiological changes in Alzheimer's disease |
- | Review, | AD, | NA |
204- | MFrot, | MF, | Rotating magnetic field improved cognitive and memory impairments in a sporadic ad model of mice by regulating microglial polarization |
- | in-vivo, | AD, | NA |
212- | MFrot, | MF, | Rotating magnetic field inhibits Aβ protein aggregation and alleviates cognitive impairment in Alzheimer’s disease mice |
- | in-vivo, | AD, | SH-SY5Y |
3745- | MFrot, | MF, | The neurobiological foundation of effective repetitive transcranial magnetic brain stimulation in Alzheimer's disease |
- | Review, | AD, | NA |
3488- | MFrot, | MF, | Rotating magnetic field improves cognitive and memory impairments in APP/PS1 mice by activating autophagy and inhibiting the PI3K/AKT/mTOR signaling pathway |
- | in-vivo, | AD, | NA |
3489- | MFrot, | MF, | Rotating magnetic field inhibits Aβ protein aggregation and alleviates cognitive impairment in Alzheimer's disease mice. |
- | in-vivo, | AD, | NA |
3834- | Moringa, | Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer's Disease-Like Pathology and Cognitive Impairments |
- | in-vivo, | AD, | NA |
3835- | Moringa, | Moringa Oleifera Alleviates Aβ Burden and Improves Synaptic Plasticity and Cognitive Impairments in APP/PS1 Mice |
- | in-vivo, | AD, | NA |
3848- | MSM, | Modulatory effect of methylsulfonylmethane against BPA/γ-radiation induced neurodegenerative alterations in rats: Influence of TREM-2/DAP-12/Syk pathway |
- | in-vitro, | AD, | NA |
3813- | mushLions, | Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer's disease-related pathologies in APPswe/PS1dE9 transgenic mice |
- | in-vitro, | AD, | NA |
3814- | mushLions, | Lion's Mane (Hericium erinaceus) Exerts Anxiolytic Effects in the rTg4510 Tau Mouse Model |
- | in-vitro, | AD, | NA |
- | in-vitro, | AD, | NA |
3810- | mushLions, | Key Mechanisms and Potential Implications of Hericium erinaceus in NLRP3 Inflammasome Activation by Reactive Oxygen Species during Alzheimer’s Disease |
- | Review, | NA, | NA |
3809- | mushLions, | The Monkey Head Mushroom and Memory Enhancement in Alzheimer's Disease |
- | Review, | NA, | NA |
3598- | PI, | Piperine attenuates cognitive impairment in an experimental mouse model of sporadic Alzheimer's disease |
- | in-vivo, | AD, | NA |
2963- | PL, | Piperlongumine activates Sirtuin1 and improves cognitive function in a murine model of Alzheimer’s disease |
- | in-vitro, | AD, | HEK293 |
3343- | QC, | Quercetin, a Flavonoid with Great Pharmacological Capacity |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Arthritis, | NA |
3380- | QC, | Quercetin as a JAK–STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases |
- | Review, | Var, | NA | - | Review, | Park, | NA | - | Review, | AD, | NA |
3374- | QC, | Therapeutic effects of quercetin in oral cancer therapy: a systematic review of preclinical evidence focused on oxidative damage, apoptosis and anti-metastasis |
- | Review, | Oral, | NA | - | Review, | AD, | NA |
3336- | QC, | Neuroprotective Effects of Quercetin in Alzheimer’s Disease |
- | Review, | AD, | NA |
3604- | QC, | Quercetin enrich diet during the early-middle not middle-late stage of alzheimer’s disease ameliorates cognitive dysfunction |
- | in-vivo, | AD, | NA |
3605- | QC, | Protective effect of quercetin in primary neurons against Aβ(1–42): relevance to Alzheimer's disease |
- | Review, | AD, | NA |
3080- | RES, | Resveratrol: A miraculous natural compound for diseases treatment |
- | Review, | Var, | NA |
3057- | RES, | The therapeutic effect of resveratrol: Focusing on the Nrf2 signaling pathway |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
3100- | RES, | Neuroprotective effects of resveratrol in Alzheimer disease pathology |
- | Review, | AD, | NA |
3613- | RES, | Resveratrol for Alzheimer's disease |
- | Review, | AD, | NA |
3612- | RES, | Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential |
- | Review, | AD, | NA |
4286- | RES, | Neuroprotective Properties of Resveratrol and Its Derivatives—Influence on Potential Mechanisms Leading to the Development of Alzheimer’s Disease |
- | Review, | AD, | NA |
4284- | RES, | Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex |
- | in-vitro, | AD, | HEK293 | - | NA, | Stroke, | NA | - | in-vivo, | AD, | NA |
3730- | RF, | Transcranial electromagnetic treatment against Alzheimer's disease: why it has the potential to trump Alzheimer's disease drug development |
- | Review, | AD, | NA |
3743- | RF, | Repeated electromagnetic field stimulation lowers amyloid-β peptide levels in primary human mixed brain tissue cultures |
- | in-vitro, | AD, | NA |
3729- | RF, | Review of the Evidence that Transcranial Electromagnetic Treatment will be a Safe and Effective Therapeutic Against Alzheimer's Disease |
- | in-vivo, | AD, | NA |
3731- | RF, | Electromagnetic field treatment protects against and reverses cognitive impairment in Alzheimer's disease mice |
- | in-vivo, | AD, | NA |
3732- | RF, | Electromagnetic treatment to old Alzheimer's mice reverses β-amyloid deposition, modifies cerebral blood flow, and provides selected cognitive benefit |
- | in-vivo, | AD, | NA |
- | in-vivo, | AD, | NA |
3738- | RF, | Electromagnetic Field Stimulation Therapy for Alzheimer's Disease |
- | Review, | AD, | NA |
3490- | RF, | Multidimensional insights into the repeated electromagnetic field stimulation and biosystems interaction in aging and age-related diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3461- | RF, | Electromagnetic Field Stimulation Therapy for Alzheimer’s Disease |
- | Review, | AD, | NA |
3616- | RosA, | Therapeutic effects of rosemary (Rosmarinus officinalis L.) and its active constituents on nervous system disorders |
- | Review, | AD, | NA |
3619- | RosA, | Rosmarinic acid suppresses Alzheimer’s disease development by reducing amyloid β aggregation by increasing monoamine secretion |
- | Review, | AD, | NA |
3620- | RosA, | Rosmarinus officinalis and Methylphenidate Exposure Improves Cognition and Depression and Regulates Anxiety-Like Behavior in AlCl3-Induced Mouse Model of Alzheimer's Disease |
- | in-vivo, | AD, | NA |
3028- | RosA, | Network pharmacology mechanism of Rosmarinus officinalis L.(Rosemary) to improve cell viability and reduces apoptosis in treating Alzheimer’s disease |
- | in-vitro, | AD, | HT22 | - | in-vivo, | NA, | NA |
3003- | RosA, | Comprehensive Insights into Biological Roles of Rosmarinic Acid: Implications in Diabetes, Cancer and Neurodegenerative Diseases |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
3932- | RT, | Rutin as a Natural Therapy for Alzheimer's Disease: Insights into its Mechanisms of Action |
- | Review, | AD, | NA |
3934- | RT, | Rutin: A Potential Therapeutic Agent for Alzheimer Disease |
- | Review, | AD, | NA |
3935- | RT, | Sodium rutin ameliorates Alzheimer's disease-like pathology by enhancing microglial amyloid-β clearance |
- | in-vivo, | AD, | NA |
3936- | RT, | Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation |
- | in-vivo, | AD, | NA |
3937- | RT, | Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease |
- | in-vivo, | AD, | NA |
4217- | Sage, | RosA, | Aroma, | Neuroprotective Potential of Aromatic Herbs: Rosemary, Sage, and Lavender |
- | Review, | AD, | NA | - | Review, | Park, | NA |
4114- | SAMe, | S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research |
- | Review, | AD, | NA |
4190- | Sesame, | Sesame Seeds: A Nutrient-Rich Superfood |
- | Review, | NA, | NA |
3664- | SFN, | Sulforaphane Upregulates the Heat Shock Protein Co-Chaperone CHIP and Clears Amyloid-β and Tau in a Mouse Model of Alzheimer's Disease |
- | in-vivo, | AD, | NA |
3663- | SFN, | Efficacy of Sulforaphane in Neurodegenerative Diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3662- | SFN, | Sulforaphane Inhibits the Generation of Amyloid-β Oligomer and Promotes Spatial Learning and Memory in Alzheimer's Disease (PS1V97L) Transgenic Mice |
- | in-vivo, | AD, | NA |
3661- | SFN, | Beneficial Effects of Sulforaphane Treatment in Alzheimer's Disease May Be Mediated through Reduced HDAC1/3 and Increased P75NTR Expression |
- | in-vitro, | AD, | NA |
3658- | SFN, | Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer’s Disease |
- | Review, | AD, | NA |
3650- | SIL, | Silibinin: a novel inhibitor of Aβ aggregation |
- | in-vitro, | AD, | SH-SY5Y |
3321- | SIL, | Silymarin (Milk thistle) |
- | Review, | AD, | NA |
3320- | SIL, | Neuroprotective Potential of Silymarin against CNS Disorders: Insight into the Pathways and Molecular Mechanisms of Action |
- | Review, | AD, | NA |
3319- | SIL, | Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms |
- | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
4123- | Silicon, | The potential influence of silica present in drinking water on Alzheimer's disease and associated disorders |
- | Review, | AD, | NA |
3958- | Taur, | Evaluation of the neuroprotective effect of taurine in Alzheimer’s disease using functional molecular imaging |
- | in-vivo, | AD, | NA |
3959- | Taur, | Taurine Directly Binds to Oligomeric Amyloid-β and Recovers Cognitive Deficits in Alzheimer Model Mice |
- | in-vivo, | AD, | NA |
3570- | TQ, | Thymoquinone alleviates the experimentally induced Alzheimer's disease inflammation by modulation of TLRs signaling |
- | in-vivo, | AD, | NA |
3571- | TQ, | The Role of Thymoquinone in Inflammatory Response in Chronic Diseases |
- | Review, | Var, | NA | - | Review, | Stroke, | NA |
3555- | TQ, | Thymoquinone administration ameliorates Alzheimer's disease-like phenotype by promoting cell survival in the hippocampus of amyloid beta1-42 infused rat model |
- | in-vivo, | AD, | NA |
3556- | TQ, | Thymoquinone alleviates the experimentally induced Alzheimer’s disease inflammation by modulation of TLRs signaling |
- | in-vivo, | AD, | NA |
3557- | TQ, | Thymoquinone protects against lipopolysaccharides-induced neurodegeneration and Alzheimer-like model in mice. |
- | in-vivo, | AD, | NA |
3559- | TQ, | Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease |
- | Review, | AD, | NA | - | Review, | Var, | NA |
3564- | TQ, | The Potential Neuroprotective Effect of Thymoquinone on Scopolamine-Induced In Vivo Alzheimer's Disease-like Condition: Mechanistic Insights |
- | in-vivo, | AD, | NA |
3565- | TQ, | Thymoquinone as a potential therapeutic for Alzheimer’s disease in transgenic Drosophila melanogaster model |
3788- | UA, | RosA, | Ursolic acid and rosmarinic acid ameliorate alterations in hippocampal neurogenesis and social memory induced by amyloid beta in mouse model of Alzheimer’s disease |
- | in-vivo, | AD, | NA |
4313- | VitA,RetA, | Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer's disease pathophysiology |
- | Review, | AD, | NA |
4314- | VitB1/Thiamine, | Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer's disease pathophysiology |
- | Review, | AD, | NA |
4312- | VitB1/Thiamine, | Pharmacological thiamine levels as a therapeutic approach in Alzheimer's disease |
- | Review, | AD, | NA |
4311- | VitB1/Thiamine, | Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy |
- | in-vivo, | AD, | NA |
4049- | VitB1/Thiamine, | Vitamin B1 (thiamine) and dementia |
- | Review, | AD, | NA |
4037- | VitB12, | FA, | Mechanistic Link between Vitamin B12 and Alzheimer’s Disease |
- | Review, | AD, | NA |
4315- | VitB2, | Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer's disease pathophysiology |
4316- | VitB3, | Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer's disease pathophysiology |
- | Review, | AD, | NA |
- | in-vivo, | AD, | NA |
4033- | VitB3, | Can nicotinamide riboside protect against cognitive impairment? |
- | in-vivo, | AD, | NA |
4317- | VitB5, | Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer's disease pathophysiology |
- | Review, | AD, | NA |
4324- | VitB5, | Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia |
- | Study, | AD, | NA | - | Study, | Park, | NA |
4329- | VitB5, | Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer's Disease Pathogenesis in a Transgenic Mouse Model |
- | in-vivo, | AD, | NA |
4320- | VitD3, | Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer's disease pathophysiology |
- | Review, | AD, | NA |
3921- | VitD3, | RES, | Vitamin D Combined with Resveratrol Prevents Cognitive Decline in SAMP8 Mice |
- | in-vivo, | AD, | NA |
4321- | VitE, | Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer's disease pathophysiology |
- | Review, | AD, | NA |
4090- | VitK2, | ProBio, | Vitamin K2 Holds Promise for Alzheimer's Prevention and Treatment |
- | Review, | AD, | NA |
4322- | VitK2, | Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer's disease pathophysiology |
- | Review, | AD, | NA |
4188- | VitK2, | Vitamin K2 protects against aluminium chloride-mediated neurodegeneration |
- | in-vivo, | NA, | NA |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1333 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid